Anti-plasmodial activity of sodium acetate in Plasmodium berghei-infected mice
| dc.contributor.author | Abdulkareem, A.O | |
| dc.contributor.author | Babamale, O.A | |
| dc.contributor.author | Owolusi, L.O | |
| dc.contributor.author | Busari, S.A | |
| dc.contributor.author | Olatunji, L.A | |
| dc.date.accessioned | 2023-04-03T07:34:05Z | |
| dc.date.available | 2023-04-03T07:34:05Z | |
| dc.date.issued | 2018-04-10 | |
| dc.description.abstract | Background: Continuous increase in drug resistance has hindered the control of malaria infection and resulted in multi-drug-resistant parasite strains. This, therefore, intensifies the search for alternative treatments with no or less side effects. Several histone deacetylase inhibitors have been characterised to possess anti-malaria activity; however, their further development as anti-malaria agents has not recorded much success. The present study investigated the anti-plasmodial activity of sodium acetate in Plasmodium berghei-infected mice, aiming at finding a better alternative source of malaria chemotherapy. Methods: Thirty female Swiss albino mice were randomly distributed into six groups. Groups A (uninfected control) and B (infected control) received only distilled water. Group C (artesunate control) were infected and treated orally with 4 mg/kg artesunate on the first day, and subsequently 2 mg/kg artesunate. Groups D, E and F were infected and orally treated with 50, 100 and 200 mg/kg sodium acetate, respectively. Results: Sodium acetate significantly lowered parasitaemia (p < 0.05) after 4 days post-treatment, and the parasite inhibition rate of 68.5% at 50 mg/kg compared favourably with the 73.3% rate of artesunate. Similarly, administration of 50 mg/kg sodium acetate improved serum total cholesterol relatively better than artesunate. Our results also revealed that sodium acetate does not interfere with liver function, as there was no significant difference (p > 0.05) in the serum activities of aspartate aminotransferase and alanine aminotransferase in both infected treated and uninfected mice. Conclusions: This study shows that sodium acetate may be a safe alternative source of anti-malaria drugs. Its effect on the serum total cholesterol also predicts its ability in correcting malaria-induced metabolic syndromes. | en_US |
| dc.identifier.uri | https://uilspace.unilorin.edu.ng/handle/20.500.12484/8968 | |
| dc.publisher | DE GRUYTER | en_US |
| dc.subject | anti-plasmodial | en_US |
| dc.subject | HDACIs | en_US |
| dc.subject | malaria | en_US |
| dc.subject | Plasmodium berghei | en_US |
| dc.subject | sodium acetate | en_US |
| dc.title | Anti-plasmodial activity of sodium acetate in Plasmodium berghei-infected mice | en_US |
| dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Abdulkareem et al., 2018.pdf
- Size:
- 135.59 KB
- Format:
- Adobe Portable Document Format
- Description:
- Research article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: